Precision BioSciences

DTIL · NASDAQ

$6.56+$0.37 (+5.98%)TodayMarket closed ·
Prev close $6.19

Who owns DTIL

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 50.7% of DTIL’s shares.

  • abrdn Inc.8.6%
  • Bleichroeder LP7.8%
  • Lynx1 Capital Advisors LLC5.4%
  • Octagon Capital Advisors LP5.2%
  • Next 6 largest institutions23.6%
  • All other shareholders49.3%
Top institutional holders of DTIL
HolderShares% of shares
abrdn Inc.2.23M8.64%
Bleichroeder LP2.02M7.82%
Lynx1 Capital Advisors LLC1.39M5.39%
Octagon Capital Advisors LP1.35M5.23%
Boothbay Fund Management, LLC1.35M5.22%
Vanguard Capital Management, LLC1.12M4.33%
BlackRock Institutional Trust Company, N.A.1.01M3.90%
Driehaus Capital Management, LLC946.71K3.67%
Benjamin (Weinstein)902.22K3.50%
Empery Asset Management, L.P.776.09K3.01%

Largest mutual fund holders

Top mutual fund holders of DTIL
HolderShares% of shares
abrdn World Healthcare Fund1.14M4.43%
abrdn Life Sciences Investors1.09M4.21%
Vanguard Total Stock Market Index Fund778.14K3.02%
iShares Russell 2000 ETF559.44K2.17%
Vanguard Extended Market Index Fund312.37K1.21%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $23.50K (2 trades) of DTIL on the open market, with no sales.

Latest DTIL insider transactions
InsiderTypeSharesValue
Brown MelindaBuy1.14K$7.12K
Germano Geno JBuy2.61K$16.38K
Brown MelindaAward20.98K—
Frankel StanleyAward20.98K—
Germano Geno JAward20.98K—
Pire Shari LisaAward20.98K—
Buehler KevinAward20.98K—
SMITH J. JEFFERSONAward57.39K—
Scimeca DarioAward107.60K—
Kelly John AlexanderAward193.69K—

Short interest

Settled Sep 30, 2026

Shares short
2.51M
Days to cover
8.81
% of shares outstanding
9.74%
Average daily volume
285.28K
Change since last report
+13.1%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.